Developing vaccines to protect against multiple coronaviruses
PanCorVac (Center for Pan-Coronavirus Vaccine Development)
['FUNDING_P01'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-10841731
This study is working on new vaccines that aim to protect against different types of coronaviruses, including the one that causes COVID-19, by focusing on parts of the virus that don't change much, so they can help keep you safe from future outbreaks.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-10841731 on ClinicalTrials.gov |
What this research studies
This research focuses on creating vaccines that provide broad protection against various coronaviruses, including SARS-CoV-2. The approach involves shifting the immune response from common viral targets to more conserved regions of the virus, which are less likely to mutate. Innovative vaccine platforms using virus-like particles will be tested for their ability to stimulate strong immune responses in animal models. If successful, these vaccines could offer long-lasting protection against future coronavirus outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of exposure to coronaviruses, including healthcare workers and those with underlying health conditions.
Not a fit: Patients who are not at risk for coronavirus infections or those who have already been vaccinated against specific strains may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to vaccines that protect against multiple strains of coronaviruses, potentially preventing future pandemics.
How similar studies have performed: Other research has shown promise in developing broad-spectrum vaccines for coronaviruses, indicating that this approach has potential for success.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KAWAOKA, YOSHIHIRO — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: KAWAOKA, YOSHIHIRO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Severe Acute Respiratory Syndrome Virus, Severe Acute Respiratory Syndrome corona virus, Severe Acute Respiratory Syndrome coronavirus, severe acute respiratory syndrome-CoV